Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Interleukin 6 receptor alpha subunit (IL6R), also known as CD126, is a type I cytokine receptor and a key component of the IL-6 signaling pathway. The functional IL-6 receptor complex consists of the IL-6 receptor alpha subunit (IL6R/CD126) and glycoprotein 130 (gp130/IL6ST), which acts as the signal transducer. IL6R mediates cellular responses to interleukin-6, which regulates cell growth, differentiation, immune response, acute-phase reactions, and hematopoiesis. There are both membrane-bound and soluble forms of IL6R, mediating classic and trans-signaling, respectively. Dysregulated production or function implicated in diseases such as multiple myeloma and autoimmune diseases.
Monoclonal antibody against human IL-6 receptor; small molecule antagonist.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 6 Receptor Alpha Subunit (IL6R).